SCHEMBL24258399

SCHEMBL24258399

C=CC(C)CC1CCC(N)CC1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CPB2 Q96IY4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20630189 0.80 CTSK (0.31)
SCHEMBL21658646 0.78 CTSK (0.33)
SCHEMBL102088 0.75 CPB2 (0.33) CPB2
SCHEMBL8352329 0.75 CPB2 (0.33) CPB2
SCHEMBL105388 0.75 CPB2 (0.33) CPB2
SCHEMBL22916593 0.73
SCHEMBL21510164 0.71 CPB2 (0.32) CPB2
SCHEMBL13717676 0.71 CPB2 (0.35) CPB2
SCHEMBL23707830 0.71 CPB2 (0.32) CPB2
SCHEMBL18988158 0.71 CPB2 (0.35) CPB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed